InsidersTradesSigma
Track the AIAIグループ(株) stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, AIAIグループ(株) has logged 2 public disclosures. Market capitalisation: €4.7bn. The latest transaction was reported on 23 March 2023 (Holding update). Among the most active insiders: UBS AG. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,984 of 28,717 companies
56.2
score / 100
Value72
Quality40
FCF yld12%
Earn yld13%
EV/EBITDA14.7x
ROE20%
Gross mgn19%
Net mgn4.2%
Debt/EBITDA11.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 March 2023
About AIAIグループ(株)
AIAI Group Inc. is a Japanese company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS market.